Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
DexCom, Inc. announced results from its CONNECT randomized controlled trial, showing that the Dexcom G7 continuous glucose monitor (CGM) significantly reduces HbA1c and improves glucose control in people with Type 2 diabetes not using insulin. These findings, presented at the American Diabetes Association's 2026 Scientific Sessions, are expected to establish a new standard of care for CGM use in this patient population. The study demonstrated an average A1C reduction of 1.6% with Dexcom G7 and showed additive benefits across various medication groups.
Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study
A study found that Dexcom's G7 continuous glucose monitor improved blood sugar control in type 2 diabetic patients who do not use insulin. Participants using the G7 saw an average 1.6% reduction in blood sugar levels after 26 weeks, a significantly greater reduction than those using self-monitoring. Dexcom CEO Jake Leach stated these results could establish a new standard of care, benefiting both clinical communities and healthcare systems.
Jim Cramer on Six Flags: “I Think It’s Too Dicey”
Jim Cramer advised against investing in Six Flags Entertainment Corporation (NYSE: FUN), calling it "too dicey" for a kids' portfolio due to perceived high risk. He suggested that other real estate investment trusts or AI stocks offer better potential for returns. Cramer expressed concern that a volatile investment in Six Flags could deter new investors from the stock market.
ETFs Investing in Apollo Global Management Inc Stocks
This article provides a comprehensive list of ETFs that hold Apollo Global Management Inc. stocks, detailing each fund's market value, weight of Apollo stock, issuer, management style, focus, expense ratio, and assets under management. The list allows investors to identify diverse ETF options, from broad market to sector-specific funds, that offer exposure to Apollo Global Management Inc.
Ingersoll Rand Inc. Income Statement – XETR:5GD
This article provides an income statement overview for Ingersoll Rand Inc. (XETR:5GD), showing its financial performance, including total revenue and net income for the last quarter. The total revenue was 1.60 B EUR, a 10.20% decrease from the previous quarter, with a net income of 166.27 M EUR for Q1 26.
Ingersoll Rand Inc. Cash Flow – XETR:5GD
Ingersoll Rand Inc. (XETR:5GD) reported its cash flow data, showing free cash flow for Q1 2026 at €141.43 million. For the full year 2025, the company recorded a free cash flow of €1.04 billion and operating cash flow of €1.15 billion. The article provides historical data for various cash flow activities.
Smurfit Westrock PLC Income Statement – XETR:N4U
The Smurfit Westrock PLC (XETR:N4U) income statement shows that the total revenue for the last quarter was 6.67 billion EUR, marking a 3.43% increase from the previous quarter. The company's net income for Q1 26 reached 56.26 million EUR. The article provides a detailed breakdown of financial metrics, including annual and quarterly data across various categories like revenue, profit, and expenses.
WEC Energy Group Inc Cash Flow – XETR:WIC
This article provides financial data for WEC Energy Group Inc (WIC) trading on XETR, focusing on its cash flow. It highlights that the free cash flow for Q1 2026 was €346.64 million, while for 2025, it was -€845.71 million with an operating cash flow of €2.90 billion. The page presents an overview of operating, investing, and financing activities, along with historical cash flow data.
Williams-Sonoma, Inc. Cash Flow – XETR:WM1
This article provides details on the cash flow of Williams-Sonoma, Inc. (XETR:WM1), indicating a free cash flow of 84.08 M EUR for Q1 2026 and 889.75 M EUR for the full year 2025. It also highlights an operating cash flow of 1.11 B EUR for 2025, with historical cash flow data available.
Globe Life Inc. Cash Flow – XETR:TMJ
This article provides financial data for Globe Life Inc. (XETR:TMJ), focusing on its cash flow activities. It reports the free cash flow for Q1 2026 as €342.77 million and for 2025 as €1.07 billion, with operating cash flow in 2025 at €1.19 billion. The data covers cash from operating, investing, and financing activities across various years.



